Naringenin, a Food-Derived Flavanone, Suppresses ITGA11-Associated Gastric Cancer Progression via the FAK/PI3K/AKT/mTOR Axis
Cancers · 24.05.2026 · 18 (11) · 1712
DOI: 10.3390/cancers18111712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 24.05.2026. Verfasst von Qiang Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery I Section, Renmin Hospital of Wuhan University, Wuhan 430060, China. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
(1)
Background
Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide. Aberrant remodeling of the extracellular matrix (ECM) is a hallmark of GC progression; however, the mechanisms by which GC cells sense and exploit ECM cues remain unclear. (2)
Methods
ITGA11 was identified through integrative bioinformatic analyses. Its expression, clinical significance, and association with ECM-related signatures were evaluated in GC tissues and public datasets. The function of ITGA11 and its role in regulating the FAK/PI3K/AKT/mTOR pathway were investigated using in vitro and in vivo assays, and the inhibitory effect of Naringenin on ITGA11-associated oncogenic activity was assessed. (3)
Results
ITGA11 was upregulated in GC tissues and correlated with an ECM-related gene signature, aggressive clinicopathological features and poor patient survival. ITGA11 promoted malignant phenotypes of GC cells in vitro and in vivo. Importantly, molecular docking and target engagement assays suggested a potential interaction between Naringenin and ITGA11. Functional experiments showed that Naringenin attenuated ITGA11-associated oncogenic activity by reducing ITGA11 levels, suppressing pathway activation, and inhibiting malignant phenotypes. (4)
Conclusions
Our findings identify ITGA11 as a potential prognostic biomarker and functional driver of GC progression and suggest that Naringenin may represent a promising bioactive compound for modulating the ITGA11/FAK/PI3K/AKT/mTOR axis in GC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery I Section, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Department of Pathology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Translational Clinical Immunology Key Laboratory, Sichuan Provincial People's Hospital, Chengdu 610072, China.
- Department of Dermatology Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China.
ORCID-Profile: Yi Wang, Qiang Tong
Zitieren
APA
Li, Q., Ye, G., Chen, F., Wang, Q., Yan, J., Wang, Y., & Tong, Q. (2026). Naringenin, a Food-Derived Flavanone, Suppresses ITGA11-Associated Gastric Cancer Progression via the FAK/PI3K/AKT/mTOR Axis. Cancers, 18(11), 1712. https://doi.org/10.3390/cancers18111712
Vancouver
Li Q, Ye G, Chen F, Wang Q, Yan J, Wang Y, et al. Naringenin, a Food-Derived Flavanone, Suppresses ITGA11-Associated Gastric Cancer Progression via the FAK/PI3K/AKT/mTOR Axis. Cancers. 2026;18(11):1712. doi:10.3390/cancers18111712
BibTeX
@article{Li2026,
author = {Li, Qiang and Ye, Guiyang and Chen, Fangfang and Wang, Qiushuang and Yan, Junfeng and Wang, Yi and Tong, Qiang},
title = {Naringenin, a Food-Derived Flavanone, Suppresses ITGA11-Associated Gastric Cancer Progression via the FAK/PI3K/AKT/mTOR Axis},
journal = {Cancers},
year = {2026},
volume = {18},
number = {11},
pages = {1712},
doi = {10.3390/cancers18111712}
}
EUVIMED